Related Experiment Video
Updated: May 18, 2026

05:59
Nasal Wipes for Influenza A Virus Detection and Isolation from Swine
Published on: December 4, 2015
Laboratory methods to study African swine fever virus
Patricia de León1, María J Bustos, Angel L Carrascosa
1Centro de Biologia Molecular Severo Ochoa (CSIC-UAM), Universidad Autonoma de Madrid, c/Nicolas Cabrera no 1, 28049 Madrid, Spain.
Virus Research
|October 9, 2012
Summary
This study explores African Swine Fever Virus (ASFV) cultivation in cell cultures and infectivity assays. It also details methods for creating attenuated ASFV vaccine strains through virus deletion mutants.
Area of Science:
- Virology
- Animal Health
- Vaccine Development
Background:
- African Swine Fever Virus (ASFV) poses a significant threat to swine populations globally.
- Effective cultivation and characterization methods are crucial for ASFV research and control.
- Developing attenuated strains is a key strategy for ASFV vaccine approaches.
Purpose of the Study:
- To summarize comparative studies on ASFV infection in various cell cultures.
- To present methods for assessing ASFV infectivity and purifying infectious virus particles.
- To outline a strategy for constructing ASFV deletion mutants for vaccine development.
Main Methods:
- Comparative analysis of ASFV components and infectious virus particle production in susceptible cell cultures.
- Description of assays to evaluate ASFV sample infectivity.
- Purification techniques for infectious ASFV particles.
- General strategy for constructing ASFV deletion mutants.
Main Results:
- Identification of optimal cell culture conditions for growing ASFV strains.
- Validation of methods for ASFV infectivity assessment and particle purification.
- Demonstration of a feasible strategy for engineering attenuated ASFV strains.
Conclusions:
- Cell cultures offer alternative means for growing ASFV field and laboratory strains.
- Established methods facilitate ASFV infectivity assays and purification.
- Virus deletion mutant construction provides a pathway for developing ASFV vaccines.

